1.Adjuvant chemoradiotherapy for postoperative head and neck squamous cell carcinoma
China Oncology 2017;27(6):463-470
Emerging clinical evidence revealed that postoperative adjuvant chemoradiotherapy (CRT) could improve the clinical outcome for resected head and neck squamous cell carcinoma in high-risk patients. The irradiation targets and doses should be determined by the primary tumor site, clinical stage, pathology reports, and the evaluation of postoperative imaging. Adjuvant concurrent CRT with cisplatin is the current standard treatment for high-risk postoperative head and neck squamous cell carcinoma patients. However, the effect of concurrent CRT with other chemotherapeutic agents and (or) epidermal growth factor receptor (EGFR) monoclonal antibody in these patients is inconclusive. Human papillomavirus (HPV)-positive oropharyngeal cancer has the unique biological characteristics, and the indications and treatment models of postoperative adjuvant CRT for these patients are still unclear. Further study is needed.
2.Research progression of microenviroment hypoxia influencing DNA damage-repair in tumour cells
Liumei TONG ; Libo FENG ; Xueguan LU
Journal of International Oncology 2009;36(11):812-814
Microenviroment hypoxia is one of the common phenomenon in cancer,studies have indiacat-ed that hypoxia induces genetic instability via activating many DNA danlage-repair signal pathways,which asso-ciates with tumor invasion and resistance and chemi-radiotherapy resistivity.Here,we overview three main DNA damage-repair pathways:mismatch repair,homologous recombination and non-homologous end joining,and how hypoxia influences their mechanisms.
3.Preliminary study on prediction of radiosensitivity of human tumor cells with fluorescence in situ hybridization
Shun WANG ; Xueguan LU ; Chaosu HU
Chinese Journal of Radiation Oncology 1992;0(01):-
Objective To investigate whether chromosome induced aberrations scored with fluorescence in situ hybridization (FISH) predict the radiosensitivity of human tumor cell lines. Methods Three human cell lines with different radiosensitivities(nasopharyngeal cell line CNE, lung adenocarcinoma cell line SPC, and breast adenocarcinoma cell line MCF 7) were used for clonogenic assay. Cells were irradiated with a dose of 1~8?Gy. Radiation induced aberration in a single chromosome (number 8) was measured at 24?h after irradiation of 2, 4 and 6?Gy.Results Radiation induced aberration in chromosome 8 reflected the radiosensitivity in CNE, SPC and MCF 7 cells 24 h after irradiation. It was associated with survival fraction at 2?Gy (r=0.96). Conclusion These results suggest that the radiation induced chromosome aberrations in interphase measured by FISH be a considerable promise for prediction of radiosensitivity in tumor cells.
4.Advances in research on ATM as a target for novel radiosensitizers
Jinsong YANG ; Xueguan LU ; Yan FENG
China Oncology 2001;0(02):-
Patients with ataxia-telangiectasia ( A-T) syndrome were charachaterized by profound hypersensitivity to ionizing radiation in clinic. Many studies have shown that this hypersensitivity possibly attributed to ATM gene whose critical compartment was ATM kinase. So inhibitors of the ATM kinase such as caffeine, pentoxifylline, methyl xanthines and 7-hydroxystaurosporine (UCN-01) were developed and have achieved a few encouraging results in basic and clinical stuides.
5.Prognostic factors of rectal cancer treated with multimodality therapy based on surgery
Chong DENG ; Xueguan LU ; Ye TIAN
Chinese Journal of Clinical Pharmacology and Therapeutics 2004;0(07):-
(0.05)). Multivariate analysis revealed that adjuvant radiotherapy and histology of tumor significantly affected the prognosis(P=(0.045) and P=(0.009), respectively). Whereas loco-regional control was only significantly affected by adjuvant radiotherapy(P=(0.000)). CONCLUSION: Adjuvant radiotherapy and histology of tumor are the important prognostic factors in the rectal cancer patients after treatment with multimodality therapy based on surgery.
6.Radiation treatment of 60 patients with cervical lymph node metastatic squamous cell carcinoma from an unknown primary site.
Xueguan LU ; Yan FENG ; Chaosu HU
Chinese Journal of Radiation Oncology 1992;0(04):-
Objective To evaluate the prognosis for patients with squamous cell carcinoma of cervical lymph node metastases from an unknown primary site who had different clinical stages and were irradiated to different fields. Methods The clinical date of 60 patients with cervical lymph node metastatic squamous cell carcinoma from an unknown primary site(no including patients with supraclavicular node metastases) were retrospectively analyzed. Results The overall 5-year survival rates(OSR) was 68.5%, the OSR of patients with N 1,N 2 and N 3 stage were 100%, 68.0% and 40.9% respectively(? 2=7.29,P=0.026). The OSR of patients with one lateral neck, whole neck and large fields irradiation were 66.5%, 74.5% and 54.6% respectively(? 2=1.38,P =0.501). The Cox proportional hazard model showed that clinical stages of cervical lymph node had an significant effect in patients survival(P=0.032). The 5-year local control rates(LCR) 65.6%, the LCR of patients with N 1,N 2 and N 3 stage were 100%, 63.2% and 34.6% respectively(? 2=5.51, P=0.064). The LCR of patients with one lateral neck, whole neck and large fields irradiation were 87.6%, 51.0% and 72.7% respectively(? 2=2.55, P =0.279). The 5-year subsequent appearance rates of occult primary cancer(SAR) was 21.2%, the SAR of patients irradiated by small(one lateral neck or whole neck) and large fields were 23.3% and 12.5% respectively(? 2=0.52, P =0.469). Conclusions The clinical stages of cervical lymph node is an important prognostic factor for survival and the local control rates has a decreasing trend as the stage increases. The subsequent appearance rates of occult primary cancer of patients irradiated by small fields has a higher trend than its of patients irradiated by large fields, but the control rates and survival rates have no significant difference in different fields irradiated.
8.The comparative analysis of nasopharyngeal carcinoma among Chinese 1992, 2008 and union for international cancer control (UICC) 2010 staging systems
Fenggang WANG ; Xueguan LU ; Jian HUAN ; Lijuan ZHOU ; Ye TIAN
Chinese Journal of Radiation Oncology 2011;20(4):270-275
Objective To compare the agreement among Chinese 1992, 2008 and UICC 2010 staging systems of nasopharyngeal carcinoma (NPC) and evaluate their predictive value of radiotherapeutic prognosis.Methods 347 NPC patients without distant metastasis treated in our hospital from 2000 to 2005 were retrospectively analyzed.Every patient was categorized into T, N, and clinical stage by Chinese 1992, 2008 and UICC 2010 staging systems, respectively.Kappa value was used to evaluate the agreement among three systems.Kaplan-Meier method was used to analyze the 5-year overall survival (OS), local-free survival (LFS) and distant metastasis-free survival (DMFS), the difference between subgroup was tested by Logrank.Results The agreement of clinical stage, T and N stage between Chinese 2008 and UICC 2010 staging system was better than that of them compared to 1992 staging system, Kappa value were 0.700、0.881 and 0.722.The agreement of T stage was better than N and clinical stage among these three staging system.The difference of OS between stageⅢ and stage Ⅳ was significant in Chinese 2008 and UICC 2010 staging system (χ2=4.48,P=0.034;χ2=8.88,P=0.003), and with no different in 1992 staging system (χ2=0.40,P=0.526).There was no significant difference of LFS between T1 and T2,T2 and T3,T3 and T4 in all staging systems (χ2=1.85,0.53,0.50,P=0.174,0.467,0.479;χ2=1.25,2.10,1.99,P=0.264,0.148,0.159;χ2=0.77,0.60,0.87, P=0.381,0.441,0.350).There were no significant differencesin 1992 staging system, while there was significant differences of DMFS between N1 and N2, N2 and N3 in 2008 stage system, N1 and N2 in UICC 2010 stage system.Conclusions The predictive value of Chinese 2008 and UICC 2010 staging system for prognosis were similar, and were better than that of 1992 staging system in NPC.
9.The selection of irradiation volume for neck lymph node-negative nasopharyngeal carcinoma: the results based on a Meta-analysis study
Jiale HUAN ; Pengfei XING ; Yingying XU ; Hongxia WANG ; Xueguan LU
Chinese Journal of Radiological Medicine and Protection 2014;34(4):275-278
Objective To study the appropriate neck irradiation volume for neck lymph nodenegative nasopharyngeal carcinoma patients by Meta-analysis.Methods The related references published from Jan 1990 to Jun 2013 were searched in Pubmed,Embase,Cochrane and Wangfang Databases.The qualified references for enrollment criteria were screened and the relative data were collected.The OR (Odds ratio) value by fixed effect model was used to evaluate the data for patients who received radiotherapy between the upper neck and whole neck irradiation.The endpoints including 5-year neck local control rate (LCR),neck-in-irradiation LCR,and neck-outsides-irradiation LCR.Results Five qualified references were screened and belonged to respective research.There enrolled 1 333 patients,including 970 patients who received the upper neck irradiation and 363 patients who received the whole neck irradiation,respectively.The forest plots revealed that there were no significant differences for 5-year neck LCR,neckin-irradiation LCR,and neck-outsides-irradiation LCR for patients received radiotherapy between the upper neck and whole neck irradiation.These OR values were 0.89 (95% CI:0.41-1.94),1.29 (95% CI:0.58-2.88) and 0.42 (95% CI:0.07-2.36),respectively.Conclusions The Meta-analysis results suggest that irradiation to the upper neck for neck lymph node-negative nasopharyngeal carcinoma can be appropriate.
10.Differences in delineation of organs at risk lead to dose uncertainties during intensity-modulated radiotherapy for nasopharynx carcinoma
Jianjun QIAN ; Pengfei XING ; Xueguan LU ; Ye TIAN
Chinese Journal of Radiation Oncology 2014;23(3):239-243
Objective To assess the differences in delineation of organs at risk (OAR) and dosimetry between junior and senior physicians during intensity-modulated radiation therapy (IMRT) for nasopharyngeal carcinoma (NPC) and to evaluate the role of specific training in reducing the differences.Methods Sixteen patients newly diagnosed with NPC were selected in the study.The OAR was delineated separately by three junior physicians and three senior physicians,and the geometric and dosimetric differences were assessed relative to the reference OAR.Delineation was performed again for the two OARs with the biggest difference after specific training in the two groups of physicians,and the differences were evaluated again.The difference was determined by paired t test.Results The maximum dose differences (Dmax) of OAR in the junior and senior physicians were (2.33 ± 12.06) % (-48.06%-137.82%) and (0.09 ± 4.72) % (-49.54%-42.96%),respectively (P =0.039),and the difference in the optic chiasm was the greatest ((5.85 ± 19.63) % ∶ (1.36 ± 4.64) %,P =0.042).The mean dose differences (Dmean) of OAR in the junior and senior physicians were (3.10 ± 8.07)% (-46.76%-59.76%) and (-0.93 ± 2.03) % (-45.54%-35.69%),respectively (P =0.021),and the difference in the parotid gland was the greatest ((13.23 ± 13.39) % ∶ (3.20 ± 6.71) %,P =0.002).In the secondary delineation after training,the Dmax of the optic chiasm in the junior and senior physicians was (1.68 ± 3.34)% and (1.50 ± 1.87) %,respectively (P =0.841),and the difference in junior physicians was reduced significantly compared with before training ((1.68 ± 3.34) % ∶ (5.85 ± 19.63) %,P =0.048) ; the Dmean of the parotid gland in the junior and senior physicians was (2.46 ± 3.06) % and (1.35 ± 3.00) %,respectively (P =0.2 7 4),significantly reduced compared with before training ((2.46 ± 3.0 6) % ∶ (13.23 ± 13.39)%,P=0.002; (1.35 ± 3.00)% ∶ (3.20 ± 6.71) %,P =0.033).Conclusions The differences in delineation of OAR lead to dose uncertainties during IMRT for NPC,and specific training can improve the accuracy of delineation.